437 related articles for article (PubMed ID: 11390562)
1. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran.
Vera DR; Wallace AM; Hoh CK; Mattrey RF
J Nucl Med; 2001 Jun; 42(6):951-9. PubMed ID: 11390562
[TBL] [Abstract][Full Text] [Related]
2. Detection of gastric and colonic sentinel nodes through endoscopic administration of 99mTc-DTPA-mannosyl-dextran in pigs.
Méndez J; Wallace AM; Hoh CK; Vera DR
J Nucl Med; 2003 Oct; 44(10):1677-81. PubMed ID: 14530486
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping.
Ellner SJ; Hoh CK; Vera DR; Darrah DD; Schulteis G; Wallace AM
Nucl Med Biol; 2003 Nov; 30(8):805-10. PubMed ID: 14698783
[TBL] [Abstract][Full Text] [Related]
4. Preclinical studies of [(99m)Tc]DTPA-mannosyl-dextran .
Hoh CK; Wallace AM; Vera DR
Nucl Med Biol; 2003 Jul; 30(5):457-64. PubMed ID: 12831982
[TBL] [Abstract][Full Text] [Related]
5. [(99m)Tc]MAG(3)-mannosyl-dextran: a receptor-binding radiopharmaceutical for sentinel node detection.
Vera DR; Wallace AM; Hoh CK
Nucl Med Biol; 2001 Jul; 28(5):493-8. PubMed ID: 11516693
[TBL] [Abstract][Full Text] [Related]
6. The synthesis of a new macromolecule for the sentinel node detection: 99mTc-gly-mannosyl-dextran.
Wang G; Wu E; Wang Y; Huang H; Zhou Y; Chen Z
Nucl Med Commun; 2019 Feb; 40(2):131-135. PubMed ID: 30461697
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a "2-day" protocol.
Wallace AM; Hoh CK; Limmer KK; Darrah DD; Schulteis G; Vera DR
Nucl Med Biol; 2009 Aug; 36(6):687-92. PubMed ID: 19647175
[TBL] [Abstract][Full Text] [Related]
8. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping.
Wallace AM; Hoh CK; Ellner SJ; Darrah DD; Schulteis G; Vera DR
Ann Surg Oncol; 2007 Feb; 14(2):913-21. PubMed ID: 17146742
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node mapping of the colon and stomach using lymphoseek in a pig model.
Ellner SJ; Méndez J; Vera DR; Hoh CK; Ashburn WL; Wallace AM
Ann Surg Oncol; 2004 Jul; 11(7):674-81. PubMed ID: 15231522
[TBL] [Abstract][Full Text] [Related]
10. New (99m)Tc(CO)(3) mannosylated dextran bearing S-derivatized cysteine chelator for sentinel lymph node detection.
Pirmettis I; Arano Y; Tsotakos T; Okada K; Yamaguchi A; Uehara T; Morais M; Correia JD; Santos I; Martins M; Pereira S; Triantis C; Kyprianidou P; Pelecanou M; Papadopoulos M
Mol Pharm; 2012 Jun; 9(6):1681-92. PubMed ID: 22519912
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek.
Wallace AM; Hoh CK; Darrah DD; Schulteis G; Vera DR
Nucl Med Biol; 2007 Oct; 34(7):849-53. PubMed ID: 17921035
[TBL] [Abstract][Full Text] [Related]
12. Use of low-dose technetium Tc 99m sulfur colloid to locate sentinel lymph nodes in melanoma of the head and neck: preliminary study.
Rasgon BM
Laryngoscope; 2001 Aug; 111(8):1366-72. PubMed ID: 11568570
[TBL] [Abstract][Full Text] [Related]
13. Injection site radioactivity of (99m)Tc-labeled mannosylated dextran for sentinel lymph node mapping.
Yamaguchi A; Hanaoka H; Pirmettis I; Uehara T; Tsushima Y; Papadopoulos M; Arano Y
Mol Pharm; 2015 Feb; 12(2):514-9. PubMed ID: 25423619
[TBL] [Abstract][Full Text] [Related]
14. Design and development of (99m)tc-'4+1'-labeled dextran-mannose derivatives as potential radiopharmaceuticals for sentinel lymph node detection.
Giglio J; Fernández S; Jentschel C; Pietzsch HJ; Papadopoulos M; Pelecanou M; Pirmettis I; Paolino A; Rey A
Cancer Biother Radiopharm; 2013 Sep; 28(7):541-51. PubMed ID: 23651043
[TBL] [Abstract][Full Text] [Related]
15. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection.
Wallace AM; Hoh CK; Vera DR; Darrah DD; Schulteis G
Ann Surg Oncol; 2003 Jun; 10(5):531-8. PubMed ID: 12794019
[TBL] [Abstract][Full Text] [Related]
16. Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: Results from a randomized, blinded clinical trial.
Unkart JT; Hosseini A; Wallace AM
J Surg Oncol; 2017 Dec; 116(7):819-823. PubMed ID: 28695567
[TBL] [Abstract][Full Text] [Related]
17. Studies toward the biological efficacy of (99m)Tc-labeled dextran-cysteine-mannose ([(99m)Tc(CO)(3)]DCM20) for sentinel lymph node detection.
Subramanian S; Pandey U; Papadopoulos M; Pirmettis I; Venkatesh M; Samuel G
Cancer Biother Radiopharm; 2012 Aug; 27(6):365-70. PubMed ID: 22690877
[TBL] [Abstract][Full Text] [Related]
18. A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer.
Leong SP; Kim J; Ross M; Faries M; Scoggins CR; Metz WL; Cope FO; Orahood RC
Ann Surg Oncol; 2011 Apr; 18(4):961-9. PubMed ID: 21331809
[TBL] [Abstract][Full Text] [Related]
19. Studying the biological feasibility of [⁹⁹mTc(CO)₃]-dextran-cysteine-cysteine-mannose as a potential molecular radiopharmaceutical for sentinel node detection.
Khan IU; Shahid A; Ahmad F; Dar UK; Ahmad M; Javed M
Ann Nucl Med; 2014 Apr; 28(3):248-56. PubMed ID: 24390658
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
